XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.2
Revenues
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenues
Note 3. Revenues
Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
JAKAFI revenues, net$705,973 $682,384 $1,277,812 $1,262,353 
OPZELURA revenues, net121,695 80,233 207,419 136,785 
ICLUSIG revenues, net26,862 29,087 57,205 56,772 
PEMAZYRE revenues, net20,269 21,572 37,945 44,047 
MINJUVI/MONJUVI revenues, net31,116 13,159 54,990 19,715 
ZYNYZ revenues, net651 570 1,118 570 
Total product revenues, net906,566 827,005 1,636,489 1,520,242 
JAKAVI product royalty revenues99,317 90,448 188,912 167,140 
OLUMIANT product royalty revenues31,702 32,009 62,291 66,164 
TABRECTA product royalty revenues5,298 4,799 10,532 8,976 
PEMAZYRE product royalty revenues876 349 1,424 761 
Total product royalty revenues137,193 127,605 263,159 243,041 
Milestone and contract revenues— — 25,000 — 
Total revenues$1,043,759 $954,610 $1,924,648 $1,763,283 
For further information on the MINJUVI/MONJUVI revenues, refer to Note 6, and for further information on our revenue-generating contracts, refer to Note 8.